Call us
07971549402




Price:
Price 1064.06 INR / Vial
Minimum Order Quantity : 100
Life Span : 24 Months
Physical Form : Tablets
Ingredients : Telmisartan 40 mg Tablet is an angiotensin II receptor blocker (ARB) that selectively antagonizes AT1 receptors, blocking vasoconstrictive and aldosteronereleasing effects of angiotensin II to reduce systemic vascular resistance and blood pressure. Used for essential hypertension (lowers SBP/DBP by 1215/810 mmHg) and cardiovascular risk reduction in highrisk patients intolerant to ACE inhibitors; provides renal protection in diabetic nephropathy by reducing proteinuria (3050%) without affecting GFR.
Drug Type : Other
Price 1125.0 INR / Number
Minimum Order Quantity : 100
Life Span : 24 months
Physical Form : Tablets
Ingredients : Metformin (SR) 500 mg + Voglibose 0.2 mg + Glimepiride 1 mg Bilayered Tablet is a triple fixeddose combination for type 2 diabetes that integrates sustainedrelease metformin (hepatic gluconeogenesis suppression), glimepiride (pancreatic insulin secretion stimulation), and voglibose (alphaglucosidase inhibition to blunt postprandial glucose spikes). This synergistic bilayer formulation provides comprehensive glycemic control (HbA1c 2.02.5%) targeting fasting, postprandial glucose, and glycemic variability, particularly effective in Indian patients with high postprandial excursions; CDSCOapproved FDC reduces pill burden while managing the "glycemic hexad." Adults: 1 tablet once daily before meals; side effects include hypoglycemia (1015%), flatulence/abdominal discomfort (vogliboserelated), GI upset (less with SR), weightneutral; contraindicated in DKA, eGFR<30 mL/min; monitor HbA1c quarterly, renal function.
Drug Type : Other
Price 1368.75 INR / Number
Minimum Order Quantity : 100
Life Span : 24 Month
Physical Form : Tablets
Ingredients : Metformin (SR) 500 mg + Pioglitazone HCl 15 mg + Glimepiride 2 mg Bilayered Tablet combines sustainedrelease metformin (hepatic glucose suppression), pioglitazone (PPAR agonist improving insulin sensitivity/adipocyte differentiation), and glimepiride (sulfonylurea stimulating insulin secretion) for comprehensive type 2 diabetes management. Triple therapy targets insulin resistance, betacell dysfunction, and hepatic gluconeogenesis, achieving HbA1c reductions of 2.22.8% in patients uncontrolled on dual therapy; pioglitazone provides additional benefits in dyslipidemia (TG 15%, HDL 10%) and atherosclerosis regression. Adults: 1 tablet once daily with meals; side effects include hypoglycemia (1520%), weight gain/edema (pioglitazone), GI upset (less with SR), HF risk (monitor NYHA Class I/II only); contraindicated in DKA, eGFR<30, bladder cancer history; check LFTs, echo periodically.
Drug Type : Other
Price 637.5 INR / Number
Minimum Order Quantity : 100
Life Span : 24 months
Physical Form : Capsules
Ingredients : Carbonyl Iron 100 mg + Folic Acid 1.5 mg + Vitamin B12 15 mcg + Zinc 61.8 mg Capsule is a hematinic combination providing highly bioavailable elemental iron (carbonyl form, gentler on stomach than ferrous salts), folate and B12 for red blood cell maturation, and zinc for immune support and hemoglobin synthesis.
Drug Type : Generic Drugs